Advanced Medical Solutions Announces Total Voting Rights Update

The latest announcement is out from Advanced Medical Solutions ( (GB:AMS) ).

Advanced Medical Solutions Group plc announced its total voting rights, with an issued share capital of 219,201,148 ordinary shares as of May 30, 2025. This information is crucial for shareholders to determine their notification obligations under the FCA’s Disclosure and Transparency Rules. The announcement reflects AMS’s commitment to transparency and regulatory compliance, potentially impacting shareholder engagement and market perception.

The most recent analyst rating on (GB:AMS) stock is a Buy with a £2.45 price target. To see the full list of analyst forecasts on Advanced Medical Solutions stock, see the GB:AMS Stock Forecast page.

Spark’s Take on GB:AMS Stock

According to Spark, TipRanks’ AI Analyst, GB:AMS is a Outperform.

Advanced Medical Solutions receives a solid score due to strong revenue growth and positive corporate developments. However, high valuation metrics and declining profitability margins slightly temper the outlook. Technical indicators suggest stable momentum, supporting the overall positive sentiment.

To see Spark’s full report on GB:AMS stock, click here.

More about Advanced Medical Solutions

Advanced Medical Solutions Group plc (AMS) is a leading developer and manufacturer of innovative tissue-healing technology, offering a variety of surgical products such as tissue adhesives, sutures, haemostats, and internal fixation devices. The company also provides wound care dressings and has expanded its portfolio through multiple acquisitions since 2019. AMS operates globally with manufacturing facilities in several countries and maintains R&D hubs in the UK, Ireland, Germany, France, and Israel.

Average Trading Volume: 1,063,670

Technical Sentiment Signal: Sell

Current Market Cap: £424.1M

See more data about AMS stock on TipRanks’ Stock Analysis page.